Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model | Science

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model | Science

Structure-guided design of SARS-CoV-2 PLpro inhibitors yields an antiviral molecule with in vivo efficacy in a mouse model…
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : ScienceMag – https://www.science.org/doi/10.1126/science.adm9724

Exit mobile version